Trust MF’s CIO, Mihir Vora, favors healthcare investments in R&D, CDMO, diagnostics, and hospitals, while being cautious about generic US pharma due to margin pressures. He anticipates a revival in the rural economy benefiting FMCG companies. Vora also foresees a multi-year upward cycle in private sector capex driven by PLI schemes and investments in green/blue hydrogen and fertilizer production.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets